News
Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.
Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...
Viral genetics is the study of the mechanisms of heritable information in viruses, including genome structure, replication and genetic change. Disease causing viruses are of particular interest ...
The agency has launched a whole genome sequencing service to monitor the virus The UK Health Security Agency (UKHSA) has announced the launch of a whole genome sequencing service to tackle hepatitis C ...
Scientists have also generated more than 17 million SARS-CoV-2 genome sequences so far, more than for any other organism. This has given an unparalleled view into the ways in which the virus ...
Hepatitis A is an infection of the liver caused by a virus. Spread through the fecal-oral route, AHS said people primarily contract hepatitis A through direct contact with an infected person but ...
The hepatitis B virus infects liver cells and is not to be confused with other types of hepatitis viruses, including the better known hepatitis A and C. The virus is spread by bodily fluids ...
Hepatitis B is a disease of the liver that is caused by hepatitis B virus and can be transmitted during birth, during sex and through blood-to-blood contact. Hepatitis B is detected by a blood test ...
Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
while current treatments suppress hepatitis B virus (HBV) replication, they don’t completely clear up the virus. The new therapies under development by Gilead and Precision will use Precision’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results